Heart Disease Trial, Recruiting (NCT06697093)

Heart Disease Trial, Recruiting NCT06697093 Sponsor: Wroclaw Medical University Condition: Heart Disease

Printed from Voxsanity (voxsanity.com.au) — NCT06697093 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Heart Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People aged 18 years or older
People who have cardiogenic shock (a condition where the heart cannot pump enough blood to meet the body's needs) of any cause, classified at a certain level of severity (SCAI stages B through E)
People whose blood pressure has been dangerously low (below 90 mmHg) for 30 minutes or more, or who need medications to keep their blood pressure or heart function stable, along with signs that vital organs are not receiving enough blood

Who may not be able to join:

People whose heart has not restarted on its own and who are being considered for a type of advanced life support machine called ECPR (a heart-lung bypass used during resuscitation)
People whose shock is caused primarily by a severe infection (septic shock), a severe allergic reaction (anaphylactic shock), or significant blood or fluid loss (hypovolemic shock)
People who developed heart failure shock as a complication directly after surgery
People with advanced, end-stage heart failure who are not considered suitable candidates for mechanical heart support devices or a heart transplant

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 6 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +48 71 736 42 51

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06697093

Sponsor: Wroclaw Medical University

Phase: Not Applicable

Status: Recruiting

Condition: Heart Disease

Trial contact: +48 71 736 42 51

More information: https://clinicaltrials.gov/study/NCT06697093

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People aged 18 years or older
People who have cardiogenic shock (a condition where the heart cannot pump enough blood to meet the body's needs) of any cause, classified at a certain level of severity (SCAI stages B through E)
People whose blood pressure has been dangerously low (below 90 mmHg) for 30 minutes or more, or who need medications to keep their blood pressure or heart function stable, along with signs that vital organs are not receiving enough blood

Who may not be able to join:

People whose heart has not restarted on its own and who are being considered for a type of advanced life support machine called ECPR (a heart-lung bypass used during resuscitation)
People whose shock is caused primarily by a severe infection (septic shock), a severe allergic reaction (anaphylactic shock), or significant blood or fluid loss (hypovolemic shock)
People who developed heart failure shock as a complication directly after surgery
People with advanced, end-stage heart failure who are not considered suitable candidates for mechanical heart support devices or a heart transplant

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 6 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Wroclaw Medical University

Registry

ClinicalTrials.gov

Start date

1 April 2025

Est. completion

1 April 2026

Where this trial is recruiting

🇵🇱 Poland

Primary endpoints

all-cause mortality

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 6 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov